Survival rates of early-stage HCV-related liver cirrhosis patients without hepatocellular carcinoma are decreased by alcohol

Journal of Clinical Biochemistry and Nutrition

Volumn 48, Issue 2, 2011, Pages 167-169

  Yamada, Masayoshi ^a   Shiroeda, Hisakazu ^a   Hayashi, Ranji ^a   Yano, Hirokazu ^a   Sato, Katsuaki ^a   Tsutsumi, Mikihiro ^a   Arisawa, Tomiyasu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Alcoholic liver disease; Hepatitis C virus; Hepatocellular carcinoma; Prognosis of liver cirrhosis

Indexed keywords

ADULT; ALCOHOL ABUSE; ALCOHOL LIVER CIRRHOSIS; ARTICLE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS; HEPATITIS C VIRUS; HUMAN; JAPANESE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; SURVIVAL RATE;

HEPATITIS C VIRUS;

EID: 79952398193     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.09-119GFR     Document Type: Article

References (16)

1. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med 2000; 160: 3227-3230.
2. Bosch FX, Ribes J. Epidemiology of liver cancer in Europe. Can J Gastroenterol 2000; 14: 621-630.
3. Kim WR, Brown RS Jr, Terrault NA, El-Serag H. Burden of liver disease in the United States: Summary of a workshop. Hepatology 2002; 36: 227-242. (Pubitemid 34700782)
4. Colombo M, Kuo G, Choo QL, and et al. Prevalence of antibodies to hepatitis c virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1006-1008. (Pubitemid 19257916)
5. Tsutsumi M, Ishizaki M, Takada A. Relative risk for the development of hepatocellular carcinoma in alcoholic patients with cirrhosis: A multiple logistic-regression coefficient analysis. Alcohol Clin Exp Res 1996; 20: 758-762. (Pubitemid 26186946)
6. Takada A, Takase S, Tsutsumi M. Characteristic features of alcoholic liver disease in Japan: A review. Gastroenterol Jpn 1993; 28: 137-148. (Pubitemid 23114173)
7. Sorensen HT, Friis S, Olsen JH, and et al. Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark. Hepatology 1998; 28: 921-925. (Pubitemid 28450250)
8. Pares A, Barrera JM, Caballeria J, and et al. Hepatitis c virus antibodies in chronic alcoholic patients: Association with severity of liver injury. Hepatology 1990; 12: 1295-1299.
9. Takase S, Tsutsumi M, Kawahara H, Takada N, Takada A. The alcohol-altered liver membrane antibody and hepatitis c virus infection in the progression of alcoholic liver disease. Hepatology 1993; 17: 9-13. (Pubitemid 23027377)
10. Lu Y, Cederbaum AI. Cyp2e1 and oxidative liver injury by alcohol. Free Radic. Biol. Med. 2008; 44: 723-738.
11. Moriya K, Yotsuyanagi H, Shintani Y, and et al. Hepatitis c virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997; 78: 1527-1531. (Pubitemid 27343089)
12. Moriya K, Fujie H, Shintani Y, and et al. The core protein of hepatitis c virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065-1067. (Pubitemid 28417341)
13. Otani K, Korenaga M, Beard MR, and et al. Hepatitis c virus core protein, cytochrome p450 2e1, and alcohol produce combined mitochondrial injury and cytotoxicity in hepatoma cells. Gastroenterology 2005; 128: 96-107. (Pubitemid 40039962)
14. Ye J, Wang C, Sumpter R Jr, Brown MS, Goldstein JL, Gale M Jr. Disruption of hepatitis c virus rna replication through inhibition of host protein geranylgeranylation. Proc Natl Acad Sci USA 2003; 100: 15865-15870. (Pubitemid 38021081)
15. Emerit J, Samuel D, Pavio N. Cu-zn super oxide dismutase as a potential antifibrotic drug for hepatitis c related fibrosis. Biomed Pharmacother 2006; 60: 1-4. (Pubitemid 41821210)
16. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis c virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144: 705-714.